<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04230785</url>
  </required_header>
  <id_info>
    <org_study_id>EVTRNA</org_study_id>
    <nct_id>NCT04230785</nct_id>
  </id_info>
  <brief_title>Circulating Non-coding RNA in Acute Ischemic Stroke With Endovascular Treatment (EVTRNA)</brief_title>
  <acronym>EVTRNA</acronym>
  <official_title>Clinical Significance of Circulating Non-coding RNA in Acute Ischemic Stroke With Endovascular Treatment (EVTRNA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing First Hospital, Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Zhongda Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nanjing First Hospital, Nanjing Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      EVTRNA is to analyze the differentiated expression pattern of circular RNA (circRNA), long
      non-coding RNA (lncRNA) and micro-RNA (miRNA) by next-generation sequencing in acute ischemic
      stroke patients before and/or after endovascular treatment. The candidate
      circRNA/lncRNA/miRNA will be verified as the biomarker and regulator for progression and
      prognosis of acute ischemic stroke with endovascular treatment. Further, the candidate
      non-coding RNA will be used to evaluate the effect of endovascular treatment on both
      peripheral and central immune after stroke.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Noncoding RNAs have been highlighted to be involved in the pathological process of ischemic
      stroke (IS). The purpose of this protocol will investigate the differentiated expression
      pattern of circular RNA (circRNA), long non-coding RNA (lncRNA) and micro-RNA (miRNA) by
      next-generation sequencing in acute ischemic stroke patients before and/or after endovascular
      treatment. The candidate circRNA/lncRNA/miRNA will be verified as the biomarker and regulator
      for progression and prognosis of acute ischemic stroke with endovascular treatment. Further,
      the candidate non-coding RNA will be used to evaluate the effect of endovascular treatment on
      both peripheral and central immune after stroke. Distinctive expression patterns of
      circRNA/miRNA/lncRNA will be identified by the next-generation sequencing and individual
      quantitative real time polymerase chain reaction (qRT-PCR). A predictive model will be
      established using logistic regression. The panel of these altered ncRNAs may be associated
      with the immune status after acute IS and could serve as a regulator for progression and
      prognosis of acute ischemic stroke with endovascular treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 15, 2020</start_date>
  <completion_date type="Anticipated">March 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2024</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>90 Days</target_duration>
  <primary_outcome>
    <measure>Differential expression pattern of circRNA/lncRNA/miRNA in acute ischemic stroke patients before and after endovascular treatment</measure>
    <time_frame>90 days</time_frame>
    <description>Differential expression pattern of circular RNA (circRNA), long non-coding RNA (lncRNA) and micro-RNA (miRNA) will be compared in acute ischemic stroke patients before and after endovascular treatment, thus candidate circRNA/lncRNA/miRNA will be verified as biomarkers and regulators for progression and prognosis of acute ischemic stroke with endovascular treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prognostic value of circRNA/miRNA/lncRNA in acute ischemic stroke with endovascular treatment</measure>
    <time_frame>90 days</time_frame>
    <description>The prognosis of AIS patients will be analyzed between differential expressed candidate circRNA/lncRNA/miRNA after they have endovascular treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of circRNA/lncRNA/miRNA and inflammatory factors in acute ischemic stroke with endovascular treatment</measure>
    <time_frame>90 days</time_frame>
    <description>Correlation of circRNA/lncRNA/miRNA and inflammatory factors in acute ischemic stroke before and after endovascular treatment will be explored.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of circRNA/lncRNA/miRNA and stroke-associated infection</measure>
    <time_frame>90 days</time_frame>
    <description>Correlation of circRNA/lncRNA/miRNA and stroke-associated infection will be explored in acute ischemic stroke with endovascular treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dynamic changes of circRNA/lncRNA/miRNA during the follow-up period</measure>
    <time_frame>90 days</time_frame>
    <description>Dynamic changes of circRNA/lncRNA/miRNA will be explored after endovascular therapy during the follow-up period</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Stroke, Acute</condition>
  <condition>Stroke, Ischemic</condition>
  <condition>Endovascular Treatment</condition>
  <arm_group>
    <arm_group_label>AIS before EVT group</arm_group_label>
    <description>This group includes patients with acute ischemic stroke (AIS) before endovascular treatment (EVT)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AIS after EVT group</arm_group_label>
    <description>This group includes patients with acute ischemic stroke (AIS) after endovascular treatment (EVT)</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Sequencing of circRNA/lncRNA/miRNA</intervention_name>
    <description>Next generation sequencing and quantitative real-time polymerase chain reaction of circular RNA (circRNA), long non-coding RNA (lncRNA) and micro-RNA (miRNA)</description>
    <arm_group_label>AIS after EVT group</arm_group_label>
    <arm_group_label>AIS before EVT group</arm_group_label>
    <other_name>Quantitative Real-time polymerase chain reaction</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      An 10 ml peripheral venous blood will be collected from the participants before and after
      endovascular treatment
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        There will be 5 AIS patients, whose data before and after endovascular treatment will be
        applied for sequencing the differentiated expression pattern and constraction of diagnosis
        and predictive models of circRNA/lncRNA/miRNA from the circulating blood. There will be 300
        AIS patients, whose data will be applied for validation of such diagnosis and predictive
        models and investigated the effect of non-coding RNA on immune status after endovascular
        treatment.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18 years or older

          -  Confirmed acute ischemic stroke by a diffusion-weighted imaging-position lesion on
             magnetic resonance imaging (MRI) and a new lesion on a brain computed tomography (CT)
             scan

          -  Within 24 hours of symptom onset and treat with endovascular therapy

          -  Good performance status

          -  Signed an approved informed consents

        Exclusion Criteria:

          -  a history of hemorrhagic infarction, chronic kidney/liver diseases, peripheral
             arterial occlusive disease, active malignant disease, and inflammatory or infectious
             diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Junshan Zhou, M.D</last_name>
    <role>Study Chair</role>
    <affiliation>Nanjing First Hospital, Nanjing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Junshan Zhou, M.D</last_name>
    <phone>+8602587726218</phone>
    <email>zhjsh333@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Qiwen Deng, M.D</last_name>
    <phone>+8602587726218</phone>
    <email>qiw_deng@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nanjing First Hospital, Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210006</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Junshan Zhou, M.D.</last_name>
      <phone>+86025-87726218</phone>
      <email>zhjsh333@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Qiwen Deng, M.D.</last_name>
      <phone>+86025-87726218</phone>
      <email>qiw_deng@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Deng QW, Li S, Wang H, Sun HL, Zuo L, Gu ZT, Lu G, Sun CZ, Zhang HQ, Yan FL. Differential long noncoding RNA expressions in peripheral blood mononuclear cells for detection of acute ischemic stroke. Clin Sci (Lond). 2018 Jul 31;132(14):1597-1614. doi: 10.1042/CS20180411. Print 2018 Jul 31.</citation>
    <PMID>29997237</PMID>
  </reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 14, 2020</study_first_submitted>
  <study_first_submitted_qc>January 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2020</study_first_posted>
  <last_update_submitted>May 21, 2020</last_update_submitted>
  <last_update_submitted_qc>May 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>acute ischemic stroke</keyword>
  <keyword>noncoding RNA</keyword>
  <keyword>endovascular treatment</keyword>
  <keyword>clinical significance</keyword>
  <keyword>outcome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All information will be available to all researchers</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>All information will be available to all researchers when related investigation has been accepted publicly, and will be available for 5 years.</ipd_time_frame>
    <ipd_access_criteria>All information will be available to all researchers when related investigation has been accepted publicly.</ipd_access_criteria>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_type>Clinical Study Report</doc_type>
      <doc_url>http://www.ncbi.nlm.nih.gov/pubmed/?term=Differential+long+noncoding+RNA+expressions+in+peripheral+blood+mononuclear+cells+for+detection+of+acute+ischemic+stroke</doc_url>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

